Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Zeng

Showing results (1211-1220 of 1,230) with videos related to

Pageof 123
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung CancerShuai Li, Shengwu Liu, Jiehui Deng, et al.
Cell Discovery|October 26, 2021
Selective and competitive functions of the AAR and UPR pathways in stress-induced angiogenesisFan Zhang, Qi-Yu Zeng, Hao Xu, et al.
Blood|April 3, 2015
The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphomaRebecca L Boddicker, N Sertac Kip, Xiaoming Xing, et al.
Blood|May 19, 2019
Recurrent <i>MSC</i> <sup>E116K</sup> mutations in ALK-negative anaplastic large cell lymphomaRebecca A Luchtel, Michael T Zimmermann, Guangzhen Hu, et al.
The Lancet. Oncology|September 4, 2025
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trialAiping Zhou, Pengfei Shen, Juan Li, et al.
Nature Machine Intelligence|July 31, 2023
Erratum: Author Correction: Advancing COVID-19 diagnosis with privacy-preserving collaboration in artificial intelligenceXiang Bai, Hanchen Wang, Liya Ma, et al.
Frontiers in Oncology|March 13, 2023
Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway)Xiao-Dong Jiao, Bao-Dong Qin, Zhan Wang, et al.
Nature Machine Intelligence|January 24, 2024
Advancing COVID-19 diagnosis with privacy-preserving collaboration in artificial intelligenceXiang Bai, Hanchen Wang, Liya Ma, et al.
Arxiv|November 24, 2021
Advancing COVID-19 Diagnosis with Privacy-Preserving Collaboration in Artificial IntelligenceXiang Bai, Hanchen Wang, Liya Ma, et al.
American Heart Journal|January 19, 2021
Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: Rationale and design of a prospective, randomized, and multicenter DKCRUSH VIII trialZhen Ge, Jing Kan, Xiao-Fei Gao, et al.
Pageof 123

Showing results (1211-1220 of 1,230) with videos related to

Sort By:
Pageof 123
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung CancerShuai Li, Shengwu Liu, Jiehui Deng, et al.
Cell Discovery|October 26, 2021
Selective and competitive functions of the AAR and UPR pathways in stress-induced angiogenesisFan Zhang, Qi-Yu Zeng, Hao Xu, et al.
Blood|April 3, 2015
The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphomaRebecca L Boddicker, N Sertac Kip, Xiaoming Xing, et al.
Blood|May 19, 2019
Recurrent <i>MSC</i> <sup>E116K</sup> mutations in ALK-negative anaplastic large cell lymphomaRebecca A Luchtel, Michael T Zimmermann, Guangzhen Hu, et al.
The Lancet. Oncology|September 4, 2025
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trialAiping Zhou, Pengfei Shen, Juan Li, et al.
Nature Machine Intelligence|July 31, 2023
Erratum: Author Correction: Advancing COVID-19 diagnosis with privacy-preserving collaboration in artificial intelligenceXiang Bai, Hanchen Wang, Liya Ma, et al.
Frontiers in Oncology|March 13, 2023
Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway)Xiao-Dong Jiao, Bao-Dong Qin, Zhan Wang, et al.
Nature Machine Intelligence|January 24, 2024
Advancing COVID-19 diagnosis with privacy-preserving collaboration in artificial intelligenceXiang Bai, Hanchen Wang, Liya Ma, et al.
Arxiv|November 24, 2021
Advancing COVID-19 Diagnosis with Privacy-Preserving Collaboration in Artificial IntelligenceXiang Bai, Hanchen Wang, Liya Ma, et al.
American Heart Journal|January 19, 2021
Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: Rationale and design of a prospective, randomized, and multicenter DKCRUSH VIII trialZhen Ge, Jing Kan, Xiao-Fei Gao, et al.
Pageof 123